Xeris Biopharma Holdings, Inc. - Common Stock (NQ:XERS)
9.400
+0.270
(+2.96%)
Streaming Delayed Price
Updated: 11:29 AM EDT, Oct 24, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 705,464 |
| Open | 9.300 |
| Bid (Size) | 9.400 (4) |
| Ask (Size) | 9.410 (6) |
| Prev. Close | 9.130 |
| Today's Range | 9.200 - 9.485 |
| 52wk Range | 2.820 - 9.405 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®
August 25, 2025
Earnings Scheduled For August 7, 2025
August 07, 2025
Earnings Scheduled For May 8, 2025
May 08, 2025
Earnings Outlook For Xeris Biopharma Holdings
May 07, 2025
Xeris (XERS) Q2 Revenue Jumps 49%
August 07, 2025
Xeris Announces Details for Analyst & Investor Day
May 20, 2025
Xeris Announces Changes to Its Board of Directors
March 28, 2025
Xeris Biopharma - Possibly The Best Pharma Stock
March 11, 2025
These stocks are gapping in today's session
March 06, 2025
Frequently Asked Questions
Is Xeris Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Xeris Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Xeris Biopharma Holdings, Inc. - Common Stock trade on?
Xeris Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Xeris Biopharma Holdings, Inc. - Common Stock is XERS on the Nasdaq Stock Market
What is the current price of Xeris Biopharma Holdings, Inc. - Common Stock?
The current price of Xeris Biopharma Holdings, Inc. - Common Stock is 9.400
When was Xeris Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Xeris Biopharma Holdings, Inc. - Common Stock was at 10/24/25 11:29 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.